Invesco’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$711M Sell
8,338,993
-259,028
-3% -$23.1M 0.07% 240
2025
Q4
$679M Buy
8,598,021
+130,028
+2% +$10.2M 0.06% 237
2025
Q3
$677M Buy
8,467,993
+978,943
+13% +$83.5M 0.11% 210
2025
Q2
$681M Buy
7,489,050
+621,841
+9% +$56.8M 0.12% 198
2025
Q1
$643M Buy
6,867,209
+329,291
+5% +$29.5M 0.12% 190
2024
Q4
$594M Buy
6,537,918
+169,140
+3% +$16.1M 0.11% 214
2024
Q3
$661M Sell
6,368,778
-389,393
-6% -$39.7M 0.13% 174
2024
Q2
$656M Sell
6,758,171
-668,820
-9% -$61.7M 0.14% 154
2024
Q1
$669M Buy
7,426,991
+150,193
+2% +$12.7M 0.14% 149
2023
Q4
$580M Buy
7,276,798
+3,241,638
+80% +$244M 0.14% 170
2023
Q3
$287M Buy
4,035,160
+82,184
+2% +$6.14M 0.08% 353
2023
Q2
$305M Sell
3,952,976
-250,422
-6% -$19.4M 0.08% 334
2023
Q1
$316M Buy
4,203,398
+72,736
+2% +$5.41M 0.09% 303
2022
Q4
$325M Buy
4,130,662
+21,318
+0.5% +$1.6M 0.1% 293
2022
Q3
$289M Sell
4,109,344
-1,322,502
-24% -$104M 0.09% 294
2022
Q2
$435M Sell
5,431,846
-196,555
-3% -$15.4M 0.13% 181
2022
Q1
$427M Buy
5,628,401
+439,579
+8% +$34.8M 0.11% 235
2021
Q4
$443M Buy
5,188,822
+516,778
+11% +$40.4M 0.11% 233
2021
Q3
$353M Buy
4,672,044
+515,649
+12% +$40.9M 0.09% 275
2021
Q2
$338M Sell
4,156,395
-262,802
-6% -$21.5M 0.08% 302
2021
Q1
$348M Sell
4,419,197
-708,917
-14% -$55.6M 0.09% 265
2020
Q4
$439M Sell
5,128,114
-190,622
-4% -$15.8M 0.13% 187
2020
Q3
$410M Sell
5,318,736
-920,028
-15% -$70.1M 0.14% 159
2020
Q2
$457M Sell
6,238,764
-2,252,900
-27% -$160M 0.16% 139
2020
Q1
$564M Buy
8,491,664
+894,945
+12% +$63.1M 0.24% 92
2019
Q4
$523M Sell
7,596,719
-837,188
-10% -$57.1M 0.16% 138
2019
Q3
$620M Sell
8,433,907
-208,137
-2% -$15.1M 0.16% 136
2019
Q2
$619M Buy
8,642,044
+5,778,145
+202% +$410M 0.16% 136
2019
Q1
$196M Buy
2,863,899
+66,511
+2% +$4.3M 0.07% 345
2018
Q4
$167M Sell
2,797,388
-393,134
-12% -$24.6M 0.06% 342
2018
Q3
$214M Buy
3,190,522
+266,721
+9% +$17.8M 0.07% 311
2018
Q2
$189M Buy
2,923,801
+807,093
+38% +$52.8M 0.06% 335
2018
Q1
$152M Buy
2,116,708
+842,743
+66% +$60.6M 0.06% 345
2017
Q4
$96.1M Sell
1,273,965
-782,640
-38% -$57.1M 0.03% 506
2017
Q3
$150M Buy
2,056,605
+1,736
+0.1% +$125K 0.06% 365
2017
Q2
$152M Buy
2,054,869
+25,996
+1% +$1.93M 0.05% 371
2017
Q1
$148M Buy
2,028,873
+83,094
+4% +$5.82M 0.05% 386
2016
Q4
$127M Buy
1,945,779
+194,064
+11% +$13.3M 0.04% 422
2016
Q3
$130M Buy
1,751,715
+48,721
+3% +$3.6M 0.04% 424
2016
Q2
$125M Buy
1,702,994
+77,387
+5% +$5.51M 0.05% 426
2016
Q1
$115M Buy
1,625,607
+119,586
+8% +$7.96M 0.05% 447
2015
Q4
$100M Buy
1,506,021
+1,140
+0.1% +$75.8K 0.04% 501
2015
Q3
$95.5M Sell
1,504,881
-108,136
-7% -$7.06M 0.04% 492
2015
Q2
$106M Sell
1,613,017
-231,294
-13% -$15.7M 0.04% 496
2015
Q1
$128M Sell
1,844,311
-211,806
-10% -$14.6M 0.05% 437
2014
Q4
$142M Buy
2,056,117
+16,066
+0.8% +$1.09M 0.06% 405
2014
Q3
$133M Buy
2,040,051
+12,389
+0.6% +$817K 0.05% 415
2014
Q2
$138M Sell
2,027,662
-90,202
-4% -$6.05M 0.05% 414
2014
Q1
$137M Sell
2,117,864
-436,657
-17% -$27.5M 0.06% 401
2013
Q4
$167M Sell
2,554,521
-22,323
-0.9% -$1.43M 0.07% 349
2013
Q3
$153M Sell
2,576,844
-16,001
-0.6% -$948K 0.07% 342
2013
Q2
$149M Buy
+2,592,845
New +$154M 0.07% 331

Other funds holding CL

Invesco's CL Position: Q1 2026 in Review

Invesco reduced its Colgate-Palmolive (CL) stake by 3% in Q1 2026, selling an estimated $23.1M and leaving 8,338,993 shares worth $711M. The position accounts for 0.07% of the portfolio, ranked #240.

Invesco first reported a position in CL in Q2 2013 and has held it in 52 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Invesco held 8,338,993 shares of Colgate-Palmolive worth $711M as of Q1 2026.
  • Invesco sold 259,028 Colgate-Palmolive shares in Q1 2026, an estimated $23.1M.
  • Colgate-Palmolive made up 0.07% of Invesco's portfolio in Q1 2026, its #240 holding.
  • Invesco first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.